However, MTC post-treatment increased the expression of Bcl-2 (Figure 4f), reduced the expression of Bax (Figure 4e) and inhibited apoptosis to exert its neuroprotective effect on cerebral ischemia-reperfusion injury. The gene discussed is BCL2; the disease is brain ischemia.